CYNTHIA KOOPMEINERS: Open Payments
NPI 1548332752 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,109 in 33 payments from 8 companies in 2025. Trend: 2023 $938 · 2024 $694 · 2025 $1,109
Food & beverage: $1,109
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 6 | $299 |
| Janssen Biotech, Inc. | 6 | $258 |
| Gilead Sciences, Inc. | 9 | $164 |
| Aimmune Therapeutics, Inc. | 2 | $146 |
| ABBVIE INC. | 4 | $106 |
| Ardelyx, Inc. | 3 | $63 |
| Ipsen Biopharmaceuticals, Inc | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: REZDIFFRA, TREMFYA, ZENPEP, IBSRELA, IQIRVO, RINVOQ, LINZESS, SKYRIZI.
Industry payments across WI — which companies pay providers there.
